CLA (CliftonLarsonAllen) Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,089
Closed -$232K 179
2021
Q3
$232K Buy
+1,089
New +$251K 0.01% 292

Other funds holding AMGN

CLA (CliftonLarsonAllen) Wealth Advisors's AMGN Position: Q4 2021 in Review

CLA (CliftonLarsonAllen) Wealth Advisors sold out of Amgen (AMGN) in Q4 2021, closing a stake of 1,089 shares — an estimated $232K sold.

CLA (CliftonLarsonAllen) Wealth Advisors first reported a position in AMGN in Q3 2021 and held it in 1 quarter. The position peaked at $232K in Q3 2021. 2,294 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

  • CLA (CliftonLarsonAllen) Wealth Advisors reported no remaining Amgen position as of Q4 2021 after selling out during the quarter.
  • CLA (CliftonLarsonAllen) Wealth Advisors sold 1,089 Amgen shares in Q4 2021, an estimated $232K.
  • CLA (CliftonLarsonAllen) Wealth Advisors first reported a position in Amgen in Q3 2021 and held it in 1 quarter.
  • CLA (CliftonLarsonAllen) Wealth Advisors's Amgen position peaked at $232K in Q3 2021.
  • 2,294 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on CLA (CliftonLarsonAllen) Wealth Advisors's 13F filing for Q4 2021, filed 26 Jan 2022.